IPO market

Unlisted Ideas

Invest in Pre-IPO shares

IPO Ideas

Invest in IPO in just 3 clicks

Goldline Pharmaceutical IPO listing date & price

Q: What is the Goldline Pharmaceutical IPO allotment date?

The Goldline Pharmaceutical IPO allotment date is when the company finalizes share allocation to applicants. After allotment, you can check your status on the registrar's portal using your application number, PAN, or DP ID.

Q: Where can I check Goldline Pharmaceutical IPO allotment status?

You can check Goldline Pharmaceutical IPO allotment status on the registrar's website or the exchange portal once allotment is finalized. You will need your application number, PAN, or DP ID/Client ID to verify your allotment.

FPSMEBSEListed

Listed at

59.75

+38.95%

Goldline Pharmaceutical IPO is a SME IPO. Issue size is 12 Cr. Price band is ₹41 to ₹43 per share. Minimum investment is ₹2.58 L. Lot size is 3000 shares. Open from 12 May 2026 to 14 May 2026. on 15 May 2026. Listing on 19 May 2026 at BSE. Managed by Cumulative Capital Pvt.Ltd. Registrar: Bigshare Services Pvt Ltd. Key details for GMP, subscription, price, , and listing in one place.

Official documents: RHP.

Follow the latest IPO & unlisted research on iOS and Android.

Google Play App Store

Goldline Pharmaceutical IPO listing date & price

FPSMEBSEListed

Listed at

59.75

+38.95%

Official documents: RHP.

Goldline Pharmaceutical IPO — listing

Official listing price and performance versus the issue price, after the stock debuts on the exchange.

Listing snapshot

Official listing versus the issue price for this debut.

Listing price

₹59.75

Vs issue price

+38.95%

Gain

Issue price

₹43

How to read this

Listing performance is the percentage move from the issue price to the first official exchange print. It reflects market pricing at listing, not advice about future returns.

Goldline Pharmaceutical IPO listing FAQs

How listing price and listing performance work.

What is the Goldline Pharmaceutical IPO listing price?

The Goldline Pharmaceutical IPO listing price is the price at which the company's shares are listed on the stock after the IPO process. It may be at a premium or discount to the issue price depending on market demand and sentiment.

When is the Goldline Pharmaceutical IPO listing date?

The Goldline Pharmaceutical IPO listing date is the date when the company's shares are listed on the stock exchanges (NSE/BSE) and become available for trading. It is usually announced after the process is completed.

What is the Goldline Pharmaceutical IPO allotment date?

The Goldline Pharmaceutical IPO date is when the company finalizes share allocation to applicants. After , you can check your status on the registrar's portal using your application number, PAN, or DP ID.

What is listing gain or loss in Goldline Pharmaceutical IPO?

Listing gain or loss is the difference between the listing price and the issue price. A positive listing gain means the share listed above the issue price; a loss means it listed below. Past listing performance does not guarantee future results.

Where can I check Goldline Pharmaceutical IPO allotment status?

You can check Goldline Pharmaceutical IPO status on the registrar's website or the portal once is finalized. You will need your application number, PAN, or DP ID/Client ID to verify your .

How is the Goldline Pharmaceutical IPO listing price determined?

The Goldline Pharmaceutical IPO listing price is determined by market demand and supply on the listing day. Factors include subscription response, company fundamentals, sector sentiment, and overall market conditions.

Can the Goldline Pharmaceutical IPO listing price differ from the issue price?

Yes, the Goldline Pharmaceutical IPO listing price can be different from the issue price. It may list at a premium (above issue price) or at a discount (below issue price) depending on market conditions at the time of listing.

How is listing performance calculated for Goldline Pharmaceutical IPO?

Listing performance for Goldline Pharmaceutical IPO is calculated as the percentage change from the issue price to the listing price. It is for informational purposes only and does not guarantee similar outcomes for other IPOs.

Follow the latest IPO & unlisted research on iOS and Android.

Google Play App Store

Explore IPO market for more details

Goldline Pharmaceutical IPO — listing

Official listing price and performance versus the issue price, after the stock debuts on the exchange.

Listing snapshot

Official listing versus the issue price for this debut.

Listing price

₹59.75

Vs issue price

+38.95%

Gain

Issue price

₹43

How to read this

Listing performance is the percentage move from the issue price to the first official exchange print. It reflects market pricing at listing, not advice about future returns.

Goldline Pharmaceutical IPO listing FAQs

How listing price and listing performance work.

What is the Goldline Pharmaceutical IPO listing price?

When is the Goldline Pharmaceutical IPO listing date?

What is the Goldline Pharmaceutical IPO allotment date?

What is listing gain or loss in Goldline Pharmaceutical IPO?

Where can I check Goldline Pharmaceutical IPO allotment status?

You can check Goldline Pharmaceutical IPO status on the registrar's website or the portal once is finalized. You will need your application number, PAN, or DP ID/Client ID to verify your .